FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4281252938> ?p ?o ?g. }

• W4281252938 abstract "The increasing prevalence of highly potent, illicitly manufactured fentanyl and its analogues (IMF) in the USA is exacerbating the opioid epidemic which has worsened during the COVID-19 pandemic. Narcan® (naloxone HCl) Nasal Spray has been approved by the US Food and Drug Administration as a treatment for opioid-related overdoses. Due to the high potency of IMF, multiple naloxone administrations (MNA) may be needed per overdose event. It is essential to determine the patterns of naloxone use, including MNA, and preferences among bystanders who have used naloxone for opioid overdose reversal.A cross-sectional web-based survey was administered to 125 adult US residents who administered 4 mg Narcan® Nasal Spray during an opioid overdose in the past year. The survey asked about the most recent overdose event, the use of Narcan® during the event and the associated withdrawal symptoms, and participant preferences regarding dosages of naloxone nasal spray. An open-ended voice survey was completed by 35 participants.Participants were mostly female (70%) and white (78%), while reported overdose events most frequently occurred in people who were males (54%) and white (86%). Most events (95%) were successfully reversed, with 78% using ≥ 2 doses and 30% using ≥ 3 doses of Narcan® Nasal Spray. Over 90% were worried that 1 Narcan® box may not be enough for a successful future reversal. Reported withdrawal symptoms were similar in overdose events where 1 versus ≥ 2 sprays were given. Eighty-six percent of participants reported more confidence in an 8 mg versus a 4 mg naloxone nasal spray and 77% reported a stronger preference for 8 mg over 4 mg.MNA occurred in most overdose events, often involving more sprays than are provided in one Narcan® nasal spray box, and participants predominantly expressed having a stronger preference for and confidence in an 8 mg compared to a 4 mg nasal spray. This suggests the need and desire for a higher dose naloxone nasal spray formulation option. Given that bystanders may be the first to administer naloxone to someone experiencing an opioid overdose, ensuring access to an adequate naloxone supply is critical in addressing the opioid overdose epidemic." @default.
• W4281252938 created "2022-05-23" @default.
• W4281252938 creator A5009172301 @default.
• W4281252938 creator A5012654372 @default.
• W4281252938 creator A5032975485 @default.
• W4281252938 creator A5042722364 @default.
• W4281252938 creator A5061497616 @default.
• W4281252938 creator A5076939645 @default.
• W4281252938 creator A5082353283 @default.
• W4281252938 date "2022-05-20" @default.
• W4281252938 modified "2023-10-03" @default.
• W4281252938 title "Real-world study of multiple naloxone administration for opioid overdose reversal among bystanders" @default.
• W4281252938 cites W1507711477 @default.
• W4281252938 cites W1968086599 @default.
• W4281252938 cites W2076045136 @default.
• W4281252938 cites W2269979437 @default.
• W4281252938 cites W2331803526 @default.
• W4281252938 cites W2605459466 @default.
• W4281252938 cites W2612593325 @default.
• W4281252938 cites W2790484282 @default.
• W4281252938 cites W2805392782 @default.
• W4281252938 cites W2921971750 @default.
• W4281252938 cites W2944343780 @default.
• W4281252938 cites W2973571955 @default.
• W4281252938 cites W2999287971 @default.
• W4281252938 cites W3002632925 @default.
• W4281252938 cites W3030926459 @default.
• W4281252938 cites W3082063364 @default.
• W4281252938 cites W3092068166 @default.
• W4281252938 cites W3159394440 @default.
• W4281252938 cites W4210495724 @default.
• W4281252938 cites W4224305150 @default.
• W4281252938 doi "https://doi.org/10.1186/s12954-022-00627-3" @default.
• W4281252938 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35596213" @default.
• W4281252938 hasPublicationYear "2022" @default.
• W4281252938 type Work @default.
• W4281252938 citedByCount "1" @default.
• W4281252938 crossrefType "journal-article" @default.
• W4281252938 hasAuthorship W4281252938A5009172301 @default.
• W4281252938 hasAuthorship W4281252938A5012654372 @default.
• W4281252938 hasAuthorship W4281252938A5032975485 @default.
• W4281252938 hasAuthorship W4281252938A5042722364 @default.
• W4281252938 hasAuthorship W4281252938A5061497616 @default.
• W4281252938 hasAuthorship W4281252938A5076939645 @default.
• W4281252938 hasAuthorship W4281252938A5082353283 @default.
• W4281252938 hasBestOaLocation W42812529381 @default.
• W4281252938 hasConcept C118552586 @default.
• W4281252938 hasConcept C126322002 @default.
• W4281252938 hasConcept C170493617 @default.
• W4281252938 hasConcept C194828623 @default.
• W4281252938 hasConcept C2778750930 @default.
• W4281252938 hasConcept C2778903686 @default.
• W4281252938 hasConcept C2779148768 @default.
• W4281252938 hasConcept C2780035454 @default.
• W4281252938 hasConcept C2780973058 @default.
• W4281252938 hasConcept C2781063702 @default.
• W4281252938 hasConcept C2781072394 @default.
• W4281252938 hasConcept C42219234 @default.
• W4281252938 hasConcept C71924100 @default.
• W4281252938 hasConcept C85663871 @default.
• W4281252938 hasConcept C98274493 @default.
• W4281252938 hasConceptScore W4281252938C118552586 @default.
• W4281252938 hasConceptScore W4281252938C126322002 @default.
• W4281252938 hasConceptScore W4281252938C170493617 @default.
• W4281252938 hasConceptScore W4281252938C194828623 @default.
• W4281252938 hasConceptScore W4281252938C2778750930 @default.
• W4281252938 hasConceptScore W4281252938C2778903686 @default.
• W4281252938 hasConceptScore W4281252938C2779148768 @default.
• W4281252938 hasConceptScore W4281252938C2780035454 @default.
• W4281252938 hasConceptScore W4281252938C2780973058 @default.
• W4281252938 hasConceptScore W4281252938C2781063702 @default.
• W4281252938 hasConceptScore W4281252938C2781072394 @default.
• W4281252938 hasConceptScore W4281252938C42219234 @default.
• W4281252938 hasConceptScore W4281252938C71924100 @default.
• W4281252938 hasConceptScore W4281252938C85663871 @default.
• W4281252938 hasConceptScore W4281252938C98274493 @default.
• W4281252938 hasIssue "1" @default.
• W4281252938 hasLocation W42812529381 @default.
• W4281252938 hasLocation W42812529382 @default.
• W4281252938 hasOpenAccess W4281252938 @default.
• W4281252938 hasPrimaryLocation W42812529381 @default.
• W4281252938 hasRelatedWork W2530122656 @default.
• W4281252938 hasRelatedWork W2759575206 @default.
• W4281252938 hasRelatedWork W2790484282 @default.
• W4281252938 hasRelatedWork W2887803294 @default.
• W4281252938 hasRelatedWork W2921971750 @default.
• W4281252938 hasRelatedWork W2982554230 @default.
• W4281252938 hasRelatedWork W3002632925 @default.
• W4281252938 hasRelatedWork W3171387315 @default.
• W4281252938 hasRelatedWork W4225293048 @default.
• W4281252938 hasRelatedWork W4253356366 @default.
• W4281252938 hasVolume "19" @default.
• W4281252938 isParatext "false" @default.
• W4281252938 isRetracted "false" @default.
• W4281252938 workType "article" @default.